Interestingly, our in vitro and in vivo results strongly suggest that RHOB is critical for both tumor growth and the apoptotic response to erlotinib, by preventing erlotinib‐induced AKT dephosphorylation and leading to the maintenance of a high level of active AKT. Here, RHOB is linked to neoplasm.